Senior Director, Strategic Pricing
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Reporting to the Vice President, US Market Access, the Sr. Director of Strategic Pricing is responsible for developing, recommending and executing gross and net pricing strategies with senior management and key customers in the payer and provider market. The role requires strong strategic thinking, knowledge of the pricing landscape in oncology and tactical support to ensure Revolution Medicines products gain formulary-policy access and reimbursement in order to not impact the ability for patients to get and remain on therapy. This role will work closely with Market Access and Commercial leadership, Finance, Supply Chain, Information Sciences as well as the broader Commercial and Medical Affairs organization.
